Methods of assessment of pre-clinical alzheimer's disease

CA3327622A1Undetermined Publication Date: 2025-10-23THE GENERAL HOSPITAL CORP +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3327622
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-15
Filing Date
2025-04-15
Publication Date
2025-10-23
Patent Text Reader

Abstract

Described herein are methods of assessing the risk of dementia in a subject using an odor-based test, or "smell test". These methods can be self-administered by the subject under the instruction of a computing device via a user interface. Methods of administering a smell test as described herein can optionally be combined with measuring and quantifying the level of at least one biomarker for dementia (e.g., CXCL10, CCL2, IL-6) in a biological sample collected from the subject. Also provided are methods to treat dementia (e.g., dementia associated with Alzheimer's disease, dementia associated with a subset of Alzheimer's disease patients with TDP-43 pathology).
Need to check novelty before this filing date? Find Prior Art